Distinct sensitivity to caffeine-induced insomnia related to age

Abstract

Caffeine acts by antagonizing the effect of the endogenous homeostatic sleep factor adenosine. In the current study we aimed to evaluate the pattern of caffeine-induced insomnia and its relation to age and sex in a general population sample derived from a web survey. The sample included 75,534 participants (28.1% men) from 18 to 75 years who answered self-report questionnaires by accessing a website in Brazilian Portuguese (BRAINSTEP project). In our sample, 3620 (17.0%) men and 9920 (18.3%) women reported insomnia due to caffeine intake. Caffeine-induced insomnia increased with aging in both men and women. This difference remained after adjusting for sociodemographic, psychiatric and sleep related variables as well as caffeine intake. Women showed higher proportion of caffeine-induced insomnia than men, but this difference did not remain after controlling for covariates. Also, individuals with caffeine-induced insomnia reported poorer sleep quality, higher latency to fall asleep and a higher proportion of psychiatric diagnoses and daily use of hypnotic drugs. In conclusion, our results show an age-associated increase in caffeine-induced insomnia and poorer mental health indicators among people with caffeine-induced insomnia complaints.

Keywords

Caffeine-induced insomnia adenosine age

Get full access to this article

View all access options for this article.

References

Ascherio

Weisskopf

O’Reilly

et al . (2004) Coffee consumption, gender, and Parkinson’s disease mortality in the cancer prevention study II cohort: The modifying effects of estrogen. Am J Epidemiol 160: 977–984.

Ascherio

Zhang

Hernán

et al . (2001) Prospective study of caffeine consumption and risk of Parkinson’s disease in men and women. Ann Neurol 50: 56–63.

Barone

Roberts

(1996) Caffeine consumption. Food Chem Toxicol 34: 119–29.

Bjorness

Kelly

Gao

et al . (2009) Control and function of the homeostatic sleep response by adenosine A1 receptors. J Neurosci 29: 1267–1276.

Bobes

González

Sáiz

et al . (2000) Propiedades psicométricas del cuestionario Oviedo de sueño. Psicothema 12: 107–112.

Bodenmann

Hohoff

Freitag

et al . (2012) Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation. Br J Pharmacol 165: 1904–1913.

Botella

Bosch

Romero

et al . (2001) Sex differences in estimation of time intervals and reaction time are removed by moderate but not high doses of caffeine in coffee. Hum Psychopharmacol 16: 533–540.

Byrne

Johnson

McRae

et al . (2012) A genome-wide association study of caffeine-related sleep disturbance: Confirmation of a role for a common variant in the adenosine receptor. Sleep 35: 967–975.

Clark

Landolt

(2017) Coffee, caffeine, and sleep: A systematic review of epidemiological studies and randomized controlled trials. Sleep Med Rev 31: 70–78.

10.

Coleman

Baghdoyan

Lydic

(2006) Dialysis delivery of an adenosine A2A agonist into the pontine reticular formation of C57BL/6J mouse increases pontine acetylcholine release and sleep. J Neurochem 96: 1750–1759.

11.

Cunha

Almeida

Ribeiro

(2001) Parallel modification of adenosine extracellular metabolism and modulatory action in the hippocampus of aged rats. J Neurochem 76: 372–382.

12.

Cunha

Constantino

Fonseca

et al . (2001) Age-dependent decrease in adenosine A1 receptor binding sites in the rat brain. Effect of cis unsaturated free fatty acids. Eur J Biochem 268(10): 2939–47.

13.

Cunha

Constantino

Sebastião

et al . (1995) Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat. Neuroreport 6: 1583–1588.

14.

Cunha

Ferré

Vaugeois

J-M

et al . (2008) Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr Pharm Des 14: 1512–1524.

15.

Curless

French

James

et al . (1993) Is caffeine a factor in subjective insomnia of elderly people? Age Ageing 22: 41–45.

16.

Eichling

Sahni

(2005) Menopause related sleep disorders. J Clin Sleep Med 1: 291–300.

17.

Fredholm

Bättig

Holmén

et al . (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51: 83–133.

18.

Freedman

Park

Abnet

et al . (2012) Association of coffee drinking with total and cause-specific mortality. N Engl J Med 366: 1891–1904.

19.

Goldstein

Kaizer

(1969) Psychotropic effects of caffeine in man. 3. A questionnaire survey of coffee drinking and its effects in a group of housewives. Clin Pharmacol Ther 10: 477–488.

20.

Hicks

Reyes

et al . (1983) Daily caffeine use and the sleep of college students. Bull Psychon Soc 21: 24–25.

21.

Hindmarch

Rigney

Stanley

et al . (2000) A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology 149: 203–216.

22.

Huang

Z-L

W-M

Eguchi

et al . (2005) Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci 8: 858–859.

23.

Huang

Z-L

Zhang

W-M

(2014) Roles of adenosine and its receptors in sleep-wake regulation. Int Rev Neurobiol 119: 349–371.

24.

Johnson-Kozlow

Kritz-Silverstein

Barrett-Connor

et al . (2002) Coffee consumption and cognitive function among older adults. Am J Epidemiol 156: 842–850.

25.

Knight

Mitchell

et al . (2004) Beverage caffeine intake in US consumers and subpopulations of interest: Estimates from the Share of Intake Panel survey. Food Chem Toxicol 42: 1923–1930.

26.

Lara

Ottoni

Brunstein

et al . (2012) Development and validity data of the Brazilian Internet Study on Temperament and Psychopathology (BRAINSTEP). J Affect Disord 141: 390–398.

27.

Lazarus

Shen

H-Y

Cherasse

et al . (2011) Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci 31: 10067–10075.

28.

Lieberman

Wurtman

Emde

et al . (1987) The effects of low doses of caffeine on human performance and mood. Psychopharmacology 92: 308–312.

29.

Lucas

Mirzaei

Pan

et al . (2011) Coffee, caffeine, and risk of depression among women. Arch Intern Med 171: 1571–1578.

30.

Lucas

Pickar

Kelsoe

et al . (1990) Effects of the acute administration of caffeine in patients with schizophrenia. Biol Psychiatry 28: 35–40.

31.

Mattis

Sehgal

(2016) Circadian rhythms, sleep, and disorders of aging. Trends Endocrinol Metab 27: 192–203.

32.

Mniszek

(1988) Brighton sleep survey: A study of sleep in 20–45-year olds. J Int Med Res 16: 61–65.

33.

Morgan

Healey

(1989) Factors influencing persistent subjective insomnia in old age: a follow-up study of good and poor sleepers aged 65 to 74. Age Ageing 18: 117–122.

34.

O’Keefe

Bhatti

Patil

et al . (2013) Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol 62: 1043–1051.

35.

Paz García-Portilla

Sáiz

Díaz-Mesa

et al . (2009) Psychometric performance of the Oviedo Sleep Questionnaire in patients with severe mental disorder. Revista de psiquiatrí́a y salud mental 2: 169–177.

36.

Porkka-Heiskanen

(2011) Methylxanthines and sleep. Handb Exp Pharmacol (200): 331–348.

37.

Rétey

Adam

Khatami

et al . (2007) A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther 81: 692–698.

38.

Ribeiro

Pfaff

Devidze

(2009) Estradiol modulates behavioral arousal and induces changes in gene expression profiles in brain regions involved in the control of vigilance. Eur J Neurosci 29: 795–801.

39.

Ritchie

Carrière

de Mendonca

et al . (2007) The neuroprotective effects of caffeine: A prospective population study (the Three City Study). Neurology 69: 536–545.

40.

Robillard

Bouchard

Cartier

et al . (2015) Sleep is more sensitive to high doses of caffeine in the middle years of life. J Psychopharmacol 29: 688–697.

41.

Rodrigues

Canas

Lopes

L V

et al . (2008) Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats. Neurobiol Aging 29: 1597–1601.

42.

Rogers

Hohoff

Heatherley

et al . (2010) Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology 35: 1973–1983.

43.

Santos

Costa

Santos

et al . (2010) Caffeine intake and dementia: Systematic review and meta-analysis. J Alzheimers Dis 20(Suppl. 1): S187–S204.

44.

Satoh

Matsumura

Koike

et al . (1999) Region-dependent difference in the sleep-promoting potency of an adenosine A2A receptor agonist. Eur J Neurosci 11: 1587–1597.

45.

Scammell

Gerashchenko

Mochizuki

et al . (2001) An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience 107: 653–663.

46.

Sebastião

Cunha

de Mendonça

et al . (2000) Modification of adenosine modulation of synaptic transmission in the hippocampus of aged rats. Br J Pharmacol 131: 1629–1634.

47.

Smit

Rogers

(2000) Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers. Psychopharmacology 152: 167–173.

48.

Smith

(2002) Effects of caffeine on human behavior. Food Chem Toxicol 40: 1243–1255.

49.

Soroko

Chang

Barrett-Connor

(1996) Reasons for changing caffeinated coffee consumption: The Rancho Bernardo Study. J Am Coll Nutr 15: 97–101.

50.

Suvi

Timpmann

Tamm

et al . (2013) Effects of caffeine on endurance capacity and psychological state in young females and males exercising in the heat. Appl Physiol Nutr Metab 42: 68–76.

51.

Van Dort

Baghdoyan

Lydic

(2009) Adenosine A1 and A2A receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal. J Neurosci 29: 871–881.

52.

Brown-Jermyn

et al . (2006) Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. J Neurosci 26: 535–541.